Cargando…
Characterization and targeting ability evaluation of cell-penetrating peptide LyP-1 modified alginate-based nanoparticles
Doxorubicin hydrochloride (DOX) shows a powerful treatment effect on breast cancer. However, for its indiscriminate distribution after systemic administration, the therapeutic response of DOX will reduce and even result in serious adverse reactions during the long-term administration. To achieve bet...
Autores principales: | Zhong, Zhirong, Cai, Liang, Li, Chunhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056619/ https://www.ncbi.nlm.nih.gov/pubmed/35516495 http://dx.doi.org/10.1039/d0ra06628a |
Ejemplares similares
-
Recent progress in LyP-1-based strategies for targeted imaging and therapy
por: Song, Ningning, et al.
Publicado: (2019) -
(64)Cu-Labeled LyP-1-Dendrimer for PET-CT Imaging of Atherosclerotic
Plaque
por: Seo, Jai Woong, et al.
Publicado: (2014) -
(99m)Tc-Labeled LyP-1 for SPECT Imaging of Triple Negative Breast Cancer
por: Song, Ningning, et al.
Publicado: (2019) -
LyP‐1‐fMWNTs enhanced targeted delivery of MBD1siRNA to pancreatic cancer cells
por: Lin, Quan‐Jun, et al.
Publicado: (2020) -
In Vitro and In Vivo Evaluation of a Cyclic LyP-1-Modified Nanosystem for Targeted Endostatin Delivery in a KYSE-30 Cell Xenograft Athymic Nude Mice Model
por: Adeyemi, Samson A., et al.
Publicado: (2022)